Evidence map›Paper›PMID 38642199›Full record

ReviewAdvances in therapy2024

Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies.

Ameya A Asarkar, Brent A Chang, Remco de Bree, Luiz P Kowalski, Orlando Guntinas-Lichius, Patrick J Bradley, Pim de Graaf, Primož Strojan, Karthik N Rao, Antti A Mäkitie and 7 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Advances in therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. The Chimeric Antero-Lateral Thigh Flap and Vastus Lateralis Muscle Flap for the Infratemporal Fossa Reconstruction in Oral Cancer Defects.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 16 institutions in 11 countries.

Ameya A AsarkarDepartment of Otolaryngology/Head and Neck Surgery, Louisiana Health Sciences Center, Shreveport, LA, 71103, USA. Ameya.asarkar@lsuhs.edu.ORCID 0000-0001-9028-8746
Brent A ChangDepartment of Otolaryngology/Head and Neck Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
Remco de BreeDepartment of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Luiz P KowalskiHead and Neck Surgery Department, University of Sao Paulo Medical School, Sao Paulo, Brazil.
Orlando Guntinas-LichiusDepartment of Otorhinolaryngology, Institute of Phoniatry/Pedaudiology, Jena University Hospital, Jena, Germany.
Patrick J BradleyDepartment of ORLHNS, Queens Medical Centre Campus, Nottingham University Hospitals, Derby Road, Nottingham, NG7 2UH, UK.ORCID 0000-0003-2810-5704
Pim de GraafAmsterdam UMC Location Vrije Universiteit, Radiology and Nuclear Medicine, de Boelelaan 1117, Amsterdam, The Netherlands.ORCID 0000-0003-1938-0747
Primož StrojanDepartment of Radiation Oncology, Institute of Oncology, 1000, Ljubljana, Slovenia.
Karthik N RaoDepartment of Head and Neck Oncology, Sri Shankara Cancer Hospital and Research Center, Bangalore, India.
Antti A MäkitieDepartment of Otorhinolaryngology, Head and Neck Surgery, Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Fernando LópezENT and Head and Neck Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Alessandra RinaldoENT Unit, Policlinico Città di Udine, 33100, Udine, Italy.ORCID 0000-0001-7956-6709
Carsten PalmeSydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
Eric M GendenDepartment of Otolaryngology-Head and Neck Surgery, Mount Sinai Medical Center, New York, NY, 10029, USA.
Alvaro SanabriaDepartment of Surgery, School of Medicine, Centro de Excelencia en Cirugia de Cabeza y Cuello-CEXCA, Universidad de Antioquia, Medellin, Colombia.
Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias, IUOPA, University of Oviedo, CIBERONC, 33011, Oviedo, Spain.
Alfio FerlitoCoordinator of the International Head and Neck Scientific Group, 35030, Padua, Italy.ORCID 0000-0002-8247-8002
Dutch Cancer Society · NLHospital Universitario Central de Asturias · ESInstitute of Oncology Ljubljana · SIJena University Hospital · DELouisiana State University Health Sciences Center Shreveport · USMayo Clinic Hospital · USMount Sinai Medical Center · USNottingham University Hospitals NHS Trust · GBSri Shankara Cancer Hospital and Research CenterThe University of Sydney · AUUniversidad de Antioquia · COUniversidad de Oviedo · ESUniversidade de São Paulo · BRUniversity Medical Center Utrecht · NLUniversity of Helsinki · FIUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLocally advanced oral cavity carcinoma (LAOCSCC) is primarily treated with surgery followed by radiotherapy with or without chemotherapy.

methodsA review of literature using PubMED was performed for studies reporting the management of LAOCSCC. Based on the reviewed literature and opinions of experts in the field, recommendations were made.

resultsStudies have shown that outcomes following resection of T4a and infranotch (inferior to mandibular notch) T4b are comparable. We discuss the concept of compartmental resection of LAOCSCC and issues concerning the management of the neck. Further, patients who refuse or are unable to undergo surgery can be treated with chemoradiotherapy with uncertain outcomes. The role of neoadjuvant chemotherapy has shown promise for organ (mandibular) preservation in a select subset of patients.

conclusionThe management strategy for LAOCSCC should be determined in a multidisciplinary setting with emphasis on tumor control, functional preservation, and quality of life of the patient.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsHumansNeoadjuvant TherapyNeoplasm StagingQuality of LifeTreatment OutcomeMarginsNeoadjuvant chemotherapy, surgeryOral cavity squamous cell carcinomaTNM

Identifiers

PMID38642199
OpenAlexW4394979298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.